Clinical Trials Logo

Bilateral Middle Ear Effusion clinical trials

View clinical trials related to Bilateral Middle Ear Effusion.

Filter by:
  • None
  • Page 1

NCT ID: NCT02350998 Completed - Clinical trials for Bilateral Middle Ear Effusion

Open-Label Study of OTO-201 for Middle Ear Effusion Evaluating Trans-Tympanostomy Tube Administration

Start date: January 2015
Phase: Phase 3
Study type: Interventional

This is a 1-month, prospective, multicenter, open-label study in pediatric subjects with bilateral middle ear effusion requiring tympanostomy tube placement. Eligible subjects will receive a single dose to each ear of 6 mg OTO-201, administered intraoperatively into the middle ear through the lumen of the tympanostomy tube (trans-tympanostomy tube TTT). The study is designed to characterize safety and any procedural issues associated with TTT drug administration of OTO-201.